Fukushima, Japan

Masataka Katohno

This inventor holds 1 USPTO granted patent. Top assignee: Kureha Corporation. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masataka Katohno. Retrieved from https://idiyas.com/inventor/masataka-katohno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masataka Katohno: Innovator in Chemical Derivatives

Introduction

Masataka Katohno is a notable inventor based in Fukushima, Japan. He has made significant contributions to the field of chemistry, particularly in the development of chemical derivatives that have practical applications in pharmaceuticals and bactericides.

Latest Patents

Masataka Katohno holds a patent for an amine derivative, specifically a benzonitrile derivative. This invention is useful as a production intermediate for benzylamine derivatives and secondary amine derivatives. The patent discloses a method for producing this benzonitrile derivative and its use as a bactericide. The chemical formulas associated with his patent detail the structure and components of the derivatives, highlighting their potential applications in various industries.

Career Highlights

Katohno is currently employed at Kureha Corporation, where he continues to innovate and develop new chemical compounds. His work has been instrumental in advancing the company's research and development efforts in the chemical sector.

Collaborations

Masataka Katohno collaborates with esteemed colleagues, including Hideki Iwama and Junko Sudo. Their combined expertise contributes to the success of their projects and the advancement of their research initiatives.

Conclusion

Masataka Katohno's contributions to the field of chemical derivatives exemplify the importance of innovation in science. His work not only enhances the capabilities of Kureha Corporation but also paves the way for future advancements in pharmaceuticals and bactericides.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…